Novo Nordisk A/S ADR buy TD Cowen
Start price
04.12.23
/
50%
€93.00
Target price
04.12.24
€106.28
Performance (%)
11.83%
End price
05.12.24
€104.00
Summary
This prediction ended on 05.12.24 with a price of €104.00. The prediction had a final performance of 11.83%. TD_Cowen has a follow-up prediction for Novo Nordisk A/S ADR where he still thinks Novo Nordisk A/S ADR is a Buy. A total of €1.08 was paid as dividends for this prediction. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -4.657% | -4.657% | -41.323% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at TD Cowen from $105.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten
Current prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.20
19.08.25
19.08.25
€60.08
19.08.26
19.08.26
-21.06%
05.06.26
05.06.26
